423 related articles for article (PubMed ID: 23512786)
21. Pretransplant model to predict posttransplant survival in liver transplant patients.
Ghobrial RM; Gornbein J; Steadman R; Danino N; Markmann JF; Holt C; Anselmo D; Amersi F; Chen P; Farmer DG; Han S; Derazo F; Saab S; Goldstein LI; McDiarmid SV; Busuttil RW
Ann Surg; 2002 Sep; 236(3):315-22; discussion 322-3. PubMed ID: 12192318
[TBL] [Abstract][Full Text] [Related]
22. Outcome and management of HCV/HIV coinfection pre- and post-liver transplantation. A 2015 update.
Miro JM; Stock P; Teicher E; Duclos-Vallée JC; Terrault N; Rimola A
J Hepatol; 2015 Mar; 62(3):701-11. PubMed ID: 25450714
[TBL] [Abstract][Full Text] [Related]
23. Risk of End-Stage Liver Disease in HIV-Viral Hepatitis Coinfected Persons in North America From the Early to Modern Antiretroviral Therapy Eras.
Klein MB; Althoff KN; Jing Y; Lau B; Kitahata M; Lo Re V; Kirk GD; Hull M; Kim HN; Sebastiani G; Moodie EE; Silverberg MJ; Sterling TR; Thorne JE; Cescon A; Napravnik S; Eron J; Gill MJ; Justice A; Peters MG; Goedert JJ; Mayor A; Thio CL; Cachay ER; Moore R; ;
Clin Infect Dis; 2016 Nov; 63(9):1160-1167. PubMed ID: 27506682
[TBL] [Abstract][Full Text] [Related]
24. Hepatitis C and the risk of kidney disease and mortality in veterans with HIV.
Fischer MJ; Wyatt CM; Gordon K; Gibert CL; Brown ST; Rimland D; Rodriguez-Barradas MC; Justice AC; Parikh CR;
J Acquir Immune Defic Syndr; 2010 Feb; 53(2):222-6. PubMed ID: 20104121
[TBL] [Abstract][Full Text] [Related]
25. Hepatitis C viremia and the risk of chronic kidney disease in HIV-infected individuals.
Lucas GM; Jing Y; Sulkowski M; Abraham AG; Estrella MM; Atta MG; Fine DM; Klein MB; Silverberg MJ; Gill MJ; Moore RD; Gebo KA; Sterling TR; Butt AA;
J Infect Dis; 2013 Oct; 208(8):1240-9. PubMed ID: 23904290
[TBL] [Abstract][Full Text] [Related]
26. Incidence of hepatocellular carcinoma in patients with chronic liver disease due to hepatitis B or C and coinfected with the human immunodeficiency virus: A retrospective cohort study.
Marcon PDS; Tovo CV; Kliemann DA; Fisch P; de Mattos AA
World J Gastroenterol; 2018 Feb; 24(5):613-622. PubMed ID: 29434450
[TBL] [Abstract][Full Text] [Related]
27. Incidence and predictors of acute kidney injury in an urban cohort of subjects with HIV and hepatitis C virus coinfection.
Garg S; Hoenig M; Edwards EM; Bliss C; Heeren T; Tumilty S; Walley AY; Koziel MJ; Skolnik PR; Horsburgh CR; Cotton D
AIDS Patient Care STDS; 2011 Mar; 25(3):135-41. PubMed ID: 21309706
[TBL] [Abstract][Full Text] [Related]
28. Hepatitis C seropositivity and kidney function decline among women with HIV: data from the Women's Interagency HIV Study.
Tsui J; Vittinghoff E; Anastos K; Augenbraun M; Young M; Nowicki M; Cohen MH; Peters MG; Golub ET; Szczech L
Am J Kidney Dis; 2009 Jul; 54(1):43-50. PubMed ID: 19394735
[TBL] [Abstract][Full Text] [Related]
29. Successful sofosbuvir-based therapy in HIV/hepatitis C virus coinfected liver transplant recipients with recurrent hepatitis C virus infection.
Grant JL; Hawkins C; Brooks H; Palella FJ; Koppe SW; Abecassis MM; Stosor V
AIDS; 2016 Jan; 30(1):93-8. PubMed ID: 26731756
[TBL] [Abstract][Full Text] [Related]
30. Improved Survival After Liver Transplantation for Patients With Human Immunodeficiency Virus (HIV) and HIV/Hepatitis C Virus Coinfection in the Integrase Strand Transfer Inhibitor and Direct-Acting Antiviral Eras.
Jacob JS; Shaikh A; Goli K; Rich NE; Benhammou JN; Ahmed A; Kim D; Rana A; Goss JA; Naggie S; Lee TH; Kanwal F; Cholankeril G
Clin Infect Dis; 2023 Feb; 76(4):592-599. PubMed ID: 36221143
[TBL] [Abstract][Full Text] [Related]
31. Rates of sustained virological response 12 weeks after the scheduled end of direct-acting antiviral (DAA)-based hepatitis C virus (HCV) therapy from the National German HCV registry: does HIV coinfection impair the response to DAA combination therapy?
Bischoff J; Mauss S; Cordes C; Lutz T; Scholten S; Moll A; Jäger H; Cornberg M; Manns MP; Baumgarten A; Rockstroh JK
HIV Med; 2018 Apr; 19(4):299-307. PubMed ID: 29368456
[TBL] [Abstract][Full Text] [Related]
32. HIV infection does not increase the risk of liver complications in hepatitis C virus-infected patient with advanced fibrosis, after sustained virological response with direct-acting antivirals.
Corma-Gómez A; Morano L; Téllez F; Rivero-Juárez A; Real LM; Alados JC; Ríos-Villegas MJ; Vera-Méndez FJ; Muñoz RP; Geijo P; Macías J; Pineda JA;
AIDS; 2019 Jun; 33(7):1167-1174. PubMed ID: 30845068
[TBL] [Abstract][Full Text] [Related]
33. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group.
Benhamou Y; Bochet M; Di Martino V; Charlotte F; Azria F; Coutellier A; Vidaud M; Bricaire F; Opolon P; Katlama C; Poynard T
Hepatology; 1999 Oct; 30(4):1054-8. PubMed ID: 10498659
[TBL] [Abstract][Full Text] [Related]
34. Kidney and liver organ transplantation in persons with human immunodeficiency virus: An Evidence-Based Analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(4):1-56. PubMed ID: 23074407
[TBL] [Abstract][Full Text] [Related]
35. Liver fibrosis progression and clinical outcomes are intertwined: role of CD4+ T-cell count and NRTI exposure from a large cohort of HIV/HCV-coinfected patients with detectable HCV-RNA: A MASTER cohort study.
Focà E; Fabbiani M; Prosperi M; Quiros Roldan E; Castelli F; Maggiolo F; Di Filippo E; Di Giambenedetto S; Gagliardini R; Saracino A; Di Pietro M; Gori A; Sighinolfi L; Pan A; Postorino MC; Torti C;
Medicine (Baltimore); 2016 Jul; 95(29):e4091. PubMed ID: 27442636
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of cryoglobulinaemia in hepatitis C virus- and hepatitis C virus/human immunodeficiency virus-infected individuals: implications for renal function.
Lapinski TW; Parfieniuk A; Rogalska-Plonska M; Czajkowska J; Flisiak R
Liver Int; 2009 Sep; 29(8):1158-61. PubMed ID: 19602133
[TBL] [Abstract][Full Text] [Related]
37. Optimal timing of hepatitis C treatment among HIV/HCV coinfected ESRD patients: Pre- vs posttransplant.
Shelton BA; Berdahl G; Sawinski D; Linas BP; Reese PP; Mustian MN; Reed RD; MacLennan PA; Locke JE
Am J Transplant; 2019 Jun; 19(6):1806-1819. PubMed ID: 30589503
[TBL] [Abstract][Full Text] [Related]
38. Incidence and predictors of cardiovascular disease, chronic kidney disease, and diabetes in HIV/HCV-coinfected patients who achieved sustained virological response.
Leone S; Prosperi M; Costarelli S; Nasta P; Maggiolo F; Di Giambenedetto S; Saracino A; Di Pietro M; Gori A
Eur J Clin Microbiol Infect Dis; 2016 Sep; 35(9):1511-20. PubMed ID: 27272121
[TBL] [Abstract][Full Text] [Related]
39. Hepatitis C virus increases the risk of kidney disease among HIV-positive patients: Systematic review and meta-analysis.
Fabrizi F; Dixit V; Martin P; Messa P
J Med Virol; 2016 Mar; 88(3):487-97. PubMed ID: 26271205
[TBL] [Abstract][Full Text] [Related]
40. Chronic kidney disease in Australian Human Immunodeficiency Virus-infected patients: Analysis of the Australian HIV Observational Database.
Cheung J; Puhr R; Petoumenos K; Cooper DA; Woolley I; Gunathilake M; Raymond N; Varma R; O'Connor CC; Gracey DM
Nephrology (Carlton); 2018 Aug; 23(8):778-786. PubMed ID: 28703924
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
